Glanbia Plc ADR (GLAPY) Upgraded by Zacks Investment Research to Hold
Glanbia Plc ADR (OTC:GLAPY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday.
According to Zacks, “Glanbia Plc engages in the manufacture and distribution of dairy and nutritional food products. Its operating segments include Glanbia Performance Nutrition, Global Ingredients, Dairy Ireland and Joint Ventures and Associates. Glanbia Performance Nutrition segment comprises of performance nutrition products under the Optimum Nutrition, BSN, Isopure, Nutramino and ABB brands. Global Ingredients segment includes American-style cheddar cheese, micro-nutrient premixes and dairy and non-dairy nutritional solutions. Dairy Ireland segment consists of consumer products and agribusiness. Joint Ventures and Associates segment covers Glanbia Ingredients Ireland, Glanbia Cheese and Southwest Cheese. Glanbia Plc is headquartered in Kilkenny, Ireland. “
Shares of Glanbia Plc ADR (GLAPY) remained flat at $101.50 during mid-day trading on Wednesday. The firm has a market capitalization of $5.99 billion and a P/E ratio of 23.63. The company has a 50-day moving average price of $101.50 and a 200 day moving average price of $99.33. Glanbia Plc ADR has a one year low of $80.15 and a one year high of $101.75.
Glanbia Plc ADR Company Profile
Glanbia plc is a global nutrition company. The Company operates through two segments: Glanbia Performance Nutrition and Glanbia Nutritionals. The Company’s Glanbia Performance Nutrition segment includes performance nutrition products. Its products are sold through a range of channels, including specialty retail, the Internet and gyms in a range of formats, including powders, bars and ready-to-drink beverages.
Receive News & Stock Ratings for Glanbia Plc ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glanbia Plc ADR and related stocks with our FREE daily email newsletter.